ProfileGDS4718 / 218547_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 94% 93% 82% 94% 89% 79% 79% 93% 92% 92% 92% 92% 91% 79% 83% 91% 89% 80% 81% 80% 93% 92% 92% 91% 91% 85% 90% 77% 92% 81% 88% 79% 93% 93% 80% 77% 84% 92% 92% 82% 91% 82% 82% 77% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]9.9788994
GSM549102patient 115, normal, homogenized [OPG study]9.7451493
GSM549104patient 119, normal, homogenized [OPG study]8.1344282
GSM549108patient 138, normal, homogenized [OPG study]9.876994
GSM549119patient 077, normal, homogenized [OPG study]9.0549789
GSM549133patient 032, cancer, homogenized [OPG study]7.8849679
GSM549139patient 042, cancer, homogenized [OPG study]7.7359379
GSM549099patient 107, normal, homogenized [OPG study]9.7787593
GSM549109patient 139, normal, homogenized [OPG study]9.6228692
GSM549110patient 046, normal, homogenized [OPG study]9.5969792
GSM549114patient 063, normal, homogenized [OPG study]9.8199692
GSM549122patient 082, normal, homogenized [OPG study]9.5523992
GSM549134patient 033, cancer, homogenized [OPG study]9.3252391
GSM549136patient 036, cancer, homogenized [OPG study]7.8646679
GSM549140patient 044, cancer, homogenized [OPG study]8.2610383
GSM549111patient 047, normal, homogenized [OPG study]9.3784391
GSM549113patient 057, normal, homogenized [OPG study]9.2131889
GSM549132patient 031, cancer, homogenized [OPG study]7.9136880
GSM549137patient 038, cancer, homogenized [OPG study]7.9979381
GSM549142patient 047, cancer, homogenized [OPG study]7.6276580
GSM549100patient 110, normal, homogenized [OPG study]9.8636193
GSM549107patient 135, normal, homogenized [OPG study]9.748692
GSM549115patient 068, normal, homogenized [OPG study]9.8212592
GSM549116patient 072, normal, homogenized [OPG study]9.4842291
GSM549120patient 078, normal, homogenized [OPG study]9.3624691
GSM549131patient 030, cancer, homogenized [OPG study]8.5757285
GSM549118patient 074, normal, homogenized [OPG study]9.2835190
GSM549129patient 027, cancer, homogenized [OPG study]7.535777
GSM549123patient 088, normal, homogenized [OPG study]9.6000892
GSM549124patient 006, cancer, homogenized [OPG study]7.8669981
GSM549126patient 015, cancer, homogenized [OPG study]8.8456888
GSM549128patient 025, cancer, homogenized [OPG study]7.8433179
GSM549103patient 117, normal, homogenized [OPG study]9.7592693
GSM549117patient 073, normal, homogenized [OPG study]10.004793
GSM549138patient 041, cancer, homogenized [OPG study]7.8816180
GSM549141patient 045, cancer, homogenized [OPG study]7.6377477
GSM549130patient 028, cancer, homogenized [OPG study]8.3174884
GSM549101patient 111, normal, homogenized [OPG study]9.465692
GSM549105patient 128, normal, homogenized [OPG study]9.5478192
GSM549106patient 134, normal, homogenized [OPG study]8.2029482
GSM549112patient 048, normal, homogenized [OPG study]9.461791
GSM549125patient 011, cancer, homogenized [OPG study]8.0136482
GSM549127patient 024, cancer, homogenized [OPG study]8.151382
GSM549135patient 035, cancer, homogenized [OPG study]7.5874577